Millennium Management Portfolio holdings
Millennium Management, founded in 1989 by Israel (Izzy) Englander and Ronald Shear and headquartered in New York City, is a global multi-strategy hedge fund managing over $71 billion in assets as of late 2024, employing a decentralized model with over 300 independent trading teams. Operating across equities, fixed income, commodities, currencies, and derivatives, the firm uses a mix of quantitative and fundamental strategies, providing its portfolio managers with capital, infrastructure, and autonomy to pursue diverse investment approaches while enforcing strict risk management. With more than 5,400 employees across offices in London, Hong Kong, Singapore, and beyond, Millennium has evolved from its initial $35 million seed capital—partly from the Belzberg family—into a titan of the hedge fund world, known for its ability to attract top talent and deliver consistent returns. Under Englander’s leadership as chairman and CEO, the firm remains a low-profile yet highly influential force in global finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
CELG
Celgene Corp
CELG
|
+$379M |
| 2 |
Starbucks
SBUX
|
+$371M |
| 3 |
APC
Anadarko Petroleum
APC
|
+$287M |
| 4 |
Bristol-Myers Squibb
BMY
|
+$263M |
| 5 |
Tesla
TSLA
|
+$253M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Fortive
FTV
|
+$1.27B |
| 2 |
ANDV
Andeavor
ANDV
|
+$1.11B |
| 3 |
AET
Aetna Inc
AET
|
+$535M |
| 4 |
Microsoft
MSFT
|
+$350M |
| 5 |
Amazon
AMZN
|
+$290M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 12.69% |
| 2 | Technology | 12.68% |
| 3 | Financials | 12.18% |
| 4 | Consumer Discretionary | 10.77% |
| 5 | Industrials | 9.47% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
OPRA
3451
Opera Ltd
OPRA
$1.7B
| $146K | ﹤0.01% |
26,241
-145,191
| -85% | -$990K |
|
3452
PUT
Prospect Capital
PSEC
$1.12B
| $146K | ﹤0.01% |
+23,200
| New | +$157K |
|
|
NEOS
3453
DELISTED
Neos Therapeutics, Inc
NEOS
| $146K | ﹤0.01% |
88,643
+17,927
| +25% | +$50.3K |
|
3454
Aquestive Therapeutics
AQST
$471M
| $145K | ﹤0.01% |
+23,010
| New | +$290K |
|
3455
Rafael Holdings
RFL
$107M
| $145K | ﹤0.01% |
18,529
-26,205
| -59% | -$218K |
|
3456
WillScot Mobile Mini Holdings
WSC
$4.64B
| $144K | ﹤0.01% |
15,338
-244,395
| -94% | -$3.46M |
|
|
BGG
3457
DELISTED
Briggs & Stratton Corp.
BGG
| $144K | ﹤0.01% |
11,019
-46,110
| -81% | -$711K |
|
|
AHRT
3458
AH Realty Trust
AHRT
$544M
| $143K | ﹤0.01% |
10,185
-48,289
| -83% | -$720K |
|
|
BFK
3459
DELISTED
BlackRock Municipal Income Trust
BFK
| $143K | ﹤0.01% |
+11,750
| New | +$145K |
|
3460
BlackRock MuniAssets Fund
MUA
$518M
| $143K | ﹤0.01% |
+11,147
| New | +$143K |
|
|
CHAP
3461
DELISTED
Chaparral Energy, Inc.
CHAP
| $143K | ﹤0.01% |
28,982
-184,589
| -86% | -$2.35M |
|
|
AVK
3462
Advent Convertible and Income Fund
AVK
$539M
| $142K | ﹤0.01% |
+11,651
| New | +$158K |
|
3463
B2Gold
BTG
$5.13B
| $142K | ﹤0.01% |
48,689
-231,460
| -83% | -$602K |
|
3464
Marchex
MCHX
$79.3M
| $142K | ﹤0.01% |
53,729
-68,146
| -56% | -$192K |
|
|
ITCI
3465
CALL
DELISTED
Intra-Cellular Therapies Inc.
ITCI
| $142K | ﹤0.01% |
+12,500
| New | +$202K |
|
3466
Galmed Pharmaceuticals
GLMD
$4.05M
| $141K | ﹤0.01% |
115
-1,719
| -94% | -$3M |
|
|
ORBC
3467
DELISTED
ORBCOMM, Inc.
ORBC
| $141K | ﹤0.01% |
17,062
-503,787
| -97% | -$4.7M |
|
3468
Inovio Pharmaceuticals
INO
$83.1M
| $140K | ﹤0.01% |
2,914
-2,556
| -47% | -$155K |
|
|
SVM
3469
Silvercorp Metals
SVM
$2.08B
| $139K | ﹤0.01% |
66,246
+41,354
| +166% | +$88.7K |
|
|
ETTX
3470
DELISTED
Entasis Therapeutics Holdings Inc.
ETTX
| $139K | ﹤0.01% |
34,143
-45,294
| -57% | -$298K |
|
|
FTD
3471
DELISTED
FTD Companies, Inc. Common Stock
FTD
| $139K | ﹤0.01% |
94,165
-184,066
| -66% | -$392K |
|
3472
BlackRock Credit Allocation Income Trust
BTZ
$932M
| $138K | ﹤0.01% |
12,340
-5,906
| -32% | -$69.1K |
|
3473
Microvision
MVIS
$86.5M
| $138K | ﹤0.01% |
227,923
-206,387
| -48% | -$194K |
|
3474
ImmunityBio
IBRX
$7.22B
| $137K | ﹤0.01% |
118,066
-7,375
| -6% | -$16.9K |
|
3475
Ribbon Communications
RBBN
$359M
| $137K | ﹤0.01% |
28,463
-60,922
| -68% | -$353K |
|
Similar funds
Millennium Management's Q4 2018 Portfolio in Review
As of Q4 2018, Millennium Management held 4,541 positions worth $64.1B, down 21% from $81.6B the previous quarter. Its ten largest holdings account for 6.7% of the portfolio.
Millennium Management withdrew a net $4.25B in Q4 2018, closing 844 positions and reducing 1,571 holdings. Its most notable exit was Andeavor, an estimated $1.11B position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 13% of assets, up from 12% a quarter earlier, followed by Technology and Financials.
Against the trend, Millennium Management opened a new position in Athenahealth, Inc. worth $135M.
- Millennium Management's largest Q4 2018 buy was Athenahealth, Inc.: 1,022,505 shares worth $135M.
- Millennium Management added most to Celgene Corp in Q4 2018, an estimated $379M increase.
- Millennium Management's biggest Q4 2018 reduction was Fortive, cutting an estimated $1.27B.
- Millennium Management fully exited Andeavor in Q4 2018, selling an estimated $1.11B.
- Millennium Management's ten largest holdings make up 6.7% of its $64.1B portfolio in Q4 2018.
- Millennium Management opened 702 new positions and closed 844 in Q4 2018.
- Millennium Management's portfolio value fell 21% quarter-over-quarter to $64.1B.
Based on Millennium Management's 13F filing for Q4 2018, filed 14 Feb 2019.